Home LiteratureArticle Details
PMID: 2550110 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Subtypes of K+ channels differentiated by the effect of K+ channel openers upon K+ channel blocker-induced seizures.

Brain research ·Vol. 495 ·No. 1 ·1989-08-21 ·Pages 189-92

Gandolfo G, Gottesmann C, Bidard JN, Lazdunski M

Abstract

Intracerebroventricular injection of mast-cell degranulating peptide (MCD), dendrotoxin I (DTXI) and 4-aminopyridine (4-AP), 3 blockers of a subclass of K+ channel, produces seizures and convulsions. Three different K+ channel openers are potent blockers of MCD-induced hyperexicitatory effects when they are administered preventively but they are unable to inhibit the epileptogenic effects induced by DTXI and 4-AP which were thought to block the same K+ channel which is blocked by MCD.

MeSH Terms
4-Aminopyridine Aminopyridines/pharmacology Animals Elapid Venoms/pharmacology Injections, Intraventricular Male Neurotoxins/pharmacology Peptides/pharmacology Potassium Channels/classification,drug effects,physiology Rats Rats, Inbred Strains Seizures/chemically induced,metabolism
Chemicals
Aminopyridines Elapid Venoms Neurotoxins Peptides Potassium Channels mast cell degranulating peptide dendrotoxin 4-Aminopyridine
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Gandolfo G
Laboratoire de Psychophysiologie, Faculté des Sciences et Techniques, Nice, France.
Gottesmann C
Bidard J N
Lazdunski M
Article Info
Journal
Brain research
Abbr.
Brain Res
ISSN
0006-8993
Published
1989-08-21
Pages
189-92
Language
English
Region
Netherlands
NLM ID
0045503
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com